BSE filing, NSE: KSE. Summary written from the filing by ALFA Finder's alert engine.
KSE Ltd: key numbers
- Share price
- ₹177.00
- Market cap
- ₹566.4 Cr
- Revenue (annual)
- ₹1,680 Cr
- Net profit (annual)
- ₹84.04 Cr
- P/E (TTM)
- 12.2×Sector 26.8×
- Promoter holding
- 22.96%+0.01% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KSE Ltd
All →KSE Management Change
KSE Limited announced the cessation of Mampilly Paul Jackson as a Non-Executive Non-Independent Director due to superannuation, effective August 29, 2026.
KSE Annual General Meeting
KSE Limited held its 62nd Annual General Meeting on August 29, 2026. Proceedings included director appointments and the approval of financial statements and dividend.
KSE Annual General Meeting
KSE Limited issued a corrigendum to its 62nd AGM notice to withdraw a resolution regarding the transfer of a company car to a director. The AGM remains scheduled for August 29, 2026.
KSE Q1 FY27 Results: Net Profit ₹0.9 Cr, Down 97.7% YoY
KSE Ltd reported revenue from operations of ₹453.7 Cr (+9.1% YoY) and net profit of ₹0.9 Cr (-97.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.9 Cr · -97.7% YoY
KSE Annual Report
KSE Limited has submitted its Annual Report for the financial year 2025-26 as required by SEBI regulations. This filing ensures regulatory compliance for annual disclosures.
KSE Annual General Meeting
KSE Limited will hold its 62nd Annual General Meeting on August 29, 2026, at its registered office in Irinjalakuda.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.